The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research.
The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.
The report also discusses key players involved in the market, such as Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others. as well as new entrants in the market. The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Get a sample of the report @ https://www.emergenresearch.com/request-sample-form/156
Key insights presented in the report:
Market revenue shares by major business players, by type, by application, and market scope of global Cell-Free DNA (cfDNA) Testing market
Sales revenue by key players and new entrants
Competitive analysis of key players, including aspects such as company overview, product or services specification, vendors, and buyers
Recent mergers, acquisitions, product launches, recent investments, and joint ventures
Regional analysis to provide insight into recent trends and opportunities
The report provides comprehensive details about the market with respect to overall revenue, sales and consumption, pricing trends, gross margins, growth rate, and market size. Additionally, the report also covers details of the company, such as sales and distribution area, product portfolios, specifications, and others.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/cell-free-dna-market
The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
North America is accounted for the largest market with a share of 33.6% in 2019, owing to the increasing chronic diseases and pregnancy problems in this region due to the changes in lifestyles of the population. Besides, the adoption of advanced technology in hospitals is also expected to boost the market shortly.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cell-Free DNA (cfDNA) testing Market Segmentation & Impact Analysis
4.1. Cell-Free DNA (cfDNA) testing Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing incidents of chronic disease
4.2.2.2. Growing demand for non-invasive testing methodologies
4.2.3. Market restraints analysis
4.2.3.1. Lack of standardization
4.2.3.2. Unfavorable legal and regulatory rules
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Cell-Free DNA (cfDNA) testing Market By Type Insights & Trends, Revenue (USD Billion)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.1. Cell-free fetal DNA (NIPT)
5.1.2. Circulating tumor DNA
5.1.3. Donor-derived cell-free DNA
Chapter 6. Cell-Free DNA (cfDNA) testing Market By Technology Insights & Trends Revenue (USD Billion)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. MPSS
6.1.2. t-MPS
6.1.3. SNP
6.1.4. Others
Chapter 7. Cell-Free DNA (cfDNA) testing Market By Application Insights & Trends Revenue (USD Billion)
7.1. Application Dynamics & Market Share, 2019 & 2027
7.1.1. Transplantation
7.1.2. Gynecology
7.1.3. Oncology
To Be Continued…!
Request customization of the report @ https://www.emergenresearch.com/request-for-customization-form/156
Thank you for reading our report. Please get in touch with us if you have any queries regarding the report or its customization. Our team will ensure the report is best suited to your needs.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com